Susquehanna International Group, LLP Alkermes Plc. Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

28 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $607,464 - $753,720	26,400 Added 106.02%	51,300 $1.44 Million
Q2 2024 Aug 15, 2024	SELL	$23.21 - $27.24 $724,152 - $849,888	-31,200 Reduced 55.61%	24,900 $600,000
Q1 2024 May 07, 2024	BUY	$26.4 - $32.56 $155,760 - $192,104	5,900 Added 11.75%	56,100 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $411,312 - $504,768	17,600 Added 53.99%	50,200 $1.39 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $1.27 Million - $1.5 Million	-46,900 Reduced 58.99%	32,600 $913,000
Q2 2023 Aug 11, 2023	BUY	$28.34 - $33.63 $393,926 - $467,457	13,900 Added 21.19%	79,500 $2.49 Million
Q1 2023 May 16, 2023	SELL	$25.31 - $29.02 $60,744 - $69,648	-2,400 Reduced 3.53%	65,600 $1.85 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $256,698 - $307,008	-11,700 Reduced 14.68%	68,000 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1.34 Million - $1.94 Million	60,900 Added 323.94%	79,700 $1.78 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $97,680 - $112,998	-3,700 Reduced 16.44%	18,800 $560,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $519,075 - $629,775	22,500 New	22,500 $592,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $1.97 Million - $2.7 Million	-84,100 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$18.78 - $25.15 $4.11 Million - $5.51 Million	-218,900 Reduced 72.24%	84,100 $2.06 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $1.13 Million - $1.44 Million	-62,000 Reduced 16.99%	303,000 $5.66 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $635,607 - $912,730	41,300 Added 12.76%	365,000 $7.28 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $1.98 Million - $2.53 Million	122,700 Added 61.04%	323,700 $5.36 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $1.85 Million - $2.69 Million	138,700 Added 222.63%	201,000 $3.9 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $497,586 - $809,243	38,100 Added 157.44%	62,300 $898,000
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $150,423 - $189,138	8,700 Added 56.13%	24,200 $494,000
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $343,376 - $427,328	-17,600 Reduced 53.17%	15,500 $302,000
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $500,251 - $869,789	23,300 Added 237.76%	33,100 $746,000
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $1.1 Million - $1.41 Million	-38,600 Reduced 79.75%	9,800 $358,000
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $7.5 Million - $12 Million	-268,400 Reduced 84.72%	48,400 $1.43 Million
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $3.37 Million - $4.02 Million	87,200 Added 37.98%	316,800 $13.4 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $3.03 Million - $3.83 Million	74,600 Added 48.13%	229,600 $9.45 Million
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $4.72 Million - $5.93 Million	88,100 Added 131.69%	155,000 $8.98 Million
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $357,675 - $415,425	-7,500 Reduced 10.08%	66,900 $3.66 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $3.66 Million - $4.05 Million	74,400	74,400 $3.78 Million

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$821 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$535 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$366 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$357 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$259 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account